Nabel, E. G. & Braunwald, E. A tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 366, 54–63 (2012).
Pedersen, F. et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J. Am. Coll. Cardiol. 64, 2101–2108 (2014).
Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 39, 119–177 (2018).
[+]
Nabel, E. G. & Braunwald, E. A tale of coronary artery disease and myocardial infarction. N. Engl. J. Med. 366, 54–63 (2012).
Pedersen, F. et al. Short- and long-term cause of death in patients treated with primary PCI for STEMI. J. Am. Coll. Cardiol. 64, 2101–2108 (2014).
Ibanez, B. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 39, 119–177 (2018).
McLeod, P., Adamson, P. D. & Coffey, S. Do we need early risk stratification after ST-elevation myocardial infarction?. Heart https://doi.org/10.1136/heartjnl-2021-320030 (2021).
Mukherjee, J. T. et al. In-hospital measurement of left ventricular ejection fraction and one-year outcomes in acute coronary syndromes: Results from the IMMEDIATE Trial. Cardiovasc. Ultrasound 14 (2016).
Marcos-Garces, V. et al. Ejection fraction by echocardiography for a selective use of magnetic resonance after infarction. Circ. Cardiovasc. Imaging 13, e011491 (2020).
Fu, Y. et al. Time to treatment influences the impact of ST-segment resolution on one-year prognosis: Insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) Trial. Circulation 104, 2653–2659 (2001).
Buller, C. E. et al. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: Insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial. Circulation 118, 1335–1346 (2008).
Matetzky, S. et al. The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA. J. Am. Coll. Cardiol. 34, 1932–1938 (1999).
Bodí, V. et al. ST-segment elevation on Q leads at rest and during exercise: Relation with myocardial viability and left ventricular remodeling within the first 6 months after infarction. Am. Heart J. 137, 1107–1115 (1999).
Husser, O. et al. The sum of ST-segment elevation is the best predictor of microvascular obstruction in patients treated successfully by primary percutaneous coronary intervention. Cardiovascular magnetic resonance study. Rev. Esp. Cardiol. 63, 1145–1154 (2010).
Rommel, K. P. et al. Prognostic significance and relationship of worst lead residual ST segment elevation with myocardial damage assessed by cardiovascular MRI in myocardial infarction. Heart 100, 1257–1263 (2014).
Goodman, S. G. et al. Development and prognosis of non-Q-wave myocardial infarction in the thrombolytic era. Am. Heart J. 144, 243–250 (2002).
Bao, M. H. et al. Prognostic implications of quantitative evaluation of baseline Q-wave width in ST-segment elevation myocardial infarction. J. Electrocardiol. 47, 465–471 (2014).
Kosmidou, I. et al. Prognostic implications of Q waves at presentation in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: An analysis of the HORIZONS-AMI study. Clin. Cardiol. 40, 982–987 (2017).
Topal, D. G. et al. Association between early Q waves and reperfusion success in patients with ST-segment–elevation myocardial infarction treated with primary percutaneous coronary intervention: A cardiac magnetic resonance imaging study. Circ. Cardiovasc. Interv. 10, e004467 (2017).
Topal, D. G. et al. Early Q-wave morphology in prediction of reperfusion success in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention—A cardiac magnetic resonance imaging study. J. Electrocardiol. 58, 135–142 (2020).
Gavara, J. et al. Magnetic resonance assessment of left ventricular ejection fraction at any time post-infarction for prediction of subsequent events in a large multicenter STEMI registry. J. Magn. Reson. Imaging 10, 11–12. https://doi.org/10.1002/jmri.27789 (2021).
Bonanad, C. et al. Prediction of long-term major events soon after a first ST-segment elevation myocardial infarction by cardiovascular magnetic resonance. Eur. J. Radiol. 85, 585–592 (2016).
McDonagh, T. A. et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur. Heart J. https://doi.org/10.1093/eurheartj/ehab368 (2021).
Bodi, V. et al. Prediction of reverse remodeling at cardiac MR imaging soon after first ST-segment-elevation myocardial infarction: Results of a large prospective registry. Radiology 278, 54–63 (2016).
Antoni, M. L. et al. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry). Am. J. Cardiol. 109, 187–194 (2012).
Bodí, V. et al. Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J. Am. Coll. Cardiol. 46, 1747–1752 (2005).
Bulluck, H., Dharmakumar, R., Arai, A. E., Berry, C. & Hausenloy, D. J. Cardiovascular magnetic resonance in acute ST-segment-elevation myocardial infarction: Recent advances, controversies, and future directions. Circulation 137, 1949–1964 (2018).
Eitel, I. et al. Comprehensive prognosis assessment by CMR imaging after ST-segment elevation myocardial infarction. J. Am. Coll. Cardiol 64, 1217–1226 (2014).
Lonborg, J. et al. Final infarct size measured by cardiovascular magnetic resonance in patients with ST elevation myocardial infarction predicts long-term clinical outcome: An observational study. Eur. Heart J. Cardiovasc. Imaging 14, 387–395 (2013).
Spitaleri, G. et al. Role of ST-segment resolution in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention (from the 5-Year outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial). Am. J. Cardiol. 121, 1039–1045 (2018).
Tomaszuk-Kazberuk, A. et al. Does lack of ST-segment resolution still have prognostic value 6 years after an acute myocardial infarction treated with coronary intervention?. Can. J. Cardiol. 27, 573–580 (2011).
De Luca, G. et al. Postprocedural single-lead ST-segment deviation and long-term mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Heart 94, 44–47 (2008).
Verouden, N. J. W. et al. Prediction of 1-year mortality with different measures of ST-segment recovery in all-comers after primary percutaneous coronary intervention for acute myocardial infarction. Circ. Cardiovasc. Qual. Outcomes 3, 522–529 (2010).
Kuijt, W. J. et al. What is the best ST-segment recovery parameter to predict clinical outcome and myocardial infarct size? Amplitude, speed, and completeness of ST-segment recovery after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J. Electrocardiol. 50, 952–959 (2017).
Bulluck, H. et al. Defining left ventricular remodeling following acute ST-segment elevation myocardial infarction using cardiovascular magnetic resonance. J. Cardiovasc. Magn. Reson. 19, 26 (2017).
van der Bijl, P. et al. Left ventricular post-infarct remodeling. JACC Heart Fail. 8, 131–140 (2020).
Rodriguez-Palomares, J. F. et al. Prognostic value of initial left ventricular remodeling in patients with reperfused STEMI. JACC Cardiovasc. Imaging 12, 2445–2456 (2019).
Gavara, J. et al. Prognostic value of strain by tissue tracking cardiac magnetic resonance after ST-segment elevation myocardial infarction. JACC Cardiovasc. Imaging 11, 1448–1457 (2018).
[-]